Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Eagle Pharmaceuticals revenue
Eagle Pharmaceuticals's revenue is $316.6 million.
What is Eagle Pharmaceuticals's revenue?
- Eagle Pharmaceuticals's peak quarterly revenue was $115.9M in 2022(q1).
- Eagle Pharmaceuticals peak revenue was $316.6M in 2022.
- Eagle Pharmaceuticals annual revenue for 2021 was 171.5M, -8.66% growth from 2020.
- Eagle Pharmaceuticals annual revenue for 2022 was 316.6M, 84.56% growth from 2021.
- Eagle Pharmaceuticals's revenue growth from 2013 to 2022 is 2,214.57%.
- Eagle Pharmaceuticals has 96 employees, and the revenue per employee ratio is $3,298,020.
On this page
Zippi applies for you, and finds you a job.
Eagle Pharmaceuticals historical revenue
Eagle Pharmaceuticals's peak revenue was $316.6M in 2022. The peak quarterly revenue was $115.9M in 2022(q1).
Eagle Pharmaceuticals's revenue increased from $13.7m in 2013 to $316.6M currently. That's a 2,214.57% change in annual revenue.
Eagle Pharmaceuticals annual revenue
Eagle Pharmaceuticals annual revenue over time
| Fiscal year / year | Eagle Pharmaceuticals revenue |
|---|---|
| 2013 | $13.7M |
| 2014 | $5.6M |
| 2015 | $66.2M |
| 2016 | $189.5M |
| 2017 | $236.7M |
| 2018 | $213.3M |
| 2019 | $195.9M |
| 2020 | $187.8M |
| 2021 | $171.5M |
| 2022 | $316.6M |
How accurately did Eagle Pharmaceuticals' revenue projections match actual performance?
Eagle Pharmaceuticals annual growth
Eagle Pharmaceuticals saw the greatest revenue growth in 2015, when revenue increased by 1,082.63%.
Eagle Pharmaceuticals had the lowest revenue growth in 2014, when revenue changed by -59.06%.
Eagle Pharmaceuticals annual growth rate over time
| Year | Eagle Pharmaceuticals growth |
|---|---|
| 2014 | -59%↓ |
| 2015 | 1083%↑ |
| 2016 | 186%↑ |
| 2017 | 25%↑ |
| 2018 | -10%↓ |
| 2019 | -8%↓ |
| 2020 | -4%↓ |
| 2021 | -9%↓ |
| 2022 | 85%↑ |
Eagle Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Eagle Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $5.6M |
| 2015 | $36.3M | $6.0M | $5.7M | $18.2M |
| 2016 | $29.6M | $40.9M | $37.8M | $81.1M |
| 2017 | $76.8M | $50.1M | $63.0M | $46.8M |
| 2018 | $46.6M | $59.3M | $51.3M | $56.1M |
| 2019 | $49.8M | $56.7M | $41.1M | $48.3M |
| 2020 | $46.0M | $41.9M | $49.9M | $49.9M |
| 2021 | $41.2M | $48.1M | $39.9M | $42.3M |
| 2022 | $115.9M | $74.1M | $65.9M | $60.7M |
| 2023 | $66.3M | $64.6M | - | - |
Eagle Pharmaceuticals jobs nearby
Do you work at Eagle Pharmaceuticals?
Is Eagle Pharmaceuticals transparent about its revenue structure?
Eagle Pharmaceuticals financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 96 |
| Date Founded | 2007 |
| Headquarters | Woodcliff Lake, New Jersey |
| Number of Locations | 2 |
| Revenue | $316.6M |
| Net Income | $35,642,000 |
| Gross Proft | $221.7M (2022) |
| PE Ratio | 17.52 |
| Tax Rate | 0.4% |
| Market Capitalization | $624.4M |
| Total Assets | $406,160,000 |
| Ticker | EGRX |
Eagle Pharmaceuticals jobs you might like
Eagle Pharmaceuticals financing
Eagle Pharmaceuticals received early financing of $12.3M on 2011-02-08.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $12.3M | 02/2011 |
Eagle Pharmaceuticals investors
| Investors | Security type |
|---|---|
| General Electric Pension Trust | |
| Steven L. Krill | |
| Paul Bruinenberg | |
| Michael Graves | |
| David E. Riggs |
Eagle Pharmaceuticals competitors
Eagle Pharmaceuticals's top competitor, Santarus, earned an annual revenue of $218.0M.
Eagle Pharmaceuticals's smallest competitor is Eton Pharmaceuticals with revenue of $959.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Aralez Pharmaceuticals | - | $105.9M | 100 | - |
| Adamis Pharmaceuticals | - | $4.8M | 131 | - |
| Eton Pharmaceuticals | - | $959,000 | 10 | - |
| Santarus | - | $218.0M | 290 | - |
| Dova Pharmaceuticals | - | $10.4M | 115 | - |
| Clovis Oncology | - | $148.8M | 468 | - |
| Veru | - | $16.3M | 252 | - |
| Mirati Therapeutics | - | $12.4M | 418 | - |
| Gossamer Bio | - | $114.7M | 100 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Eagle Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Eagle Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Eagle Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Eagle Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Eagle Pharmaceuticals. The data presented on this page does not represent the view of Eagle Pharmaceuticals and its employees or that of Zippia.
Eagle Pharmaceuticals may also be known as or be related to EAGLE PHARMACEUTICALS INC., EAGLE PHARMACEUTICALS Inc., EAGLE PHARMACEUTICALS, INC., Eagle Pharmaceuticals, Eagle Pharmaceuticals Inc and Eagle Pharmaceuticals, Inc.